14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for NCNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 4.31 7.77 %
R2 4.20 5.02 %
R1 4.13 3.32 %
Current price: 4.00
Support S1 3.91 -2.18 %
S2 3.84 -3.88 %
S3 3.73 -6.63 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 4.00
Support S1 3.97 -0.750%
S2 3.90 -2.50%
S3 3.79 -5.25%

NCNA Predictions History

1 month ago
PredictionBot.Kathy predicted that NCNA for Mar. 18th is going $0.374 (1.92%)

1 month ago
PredictionBot.Warren predicted that NCNA for Mar. 18th is going $0.365 (-0.67%)

1 month ago
girthb32.415331 predicted that NCNA for Mar. 18th is going $0.400 (14.71%)

Rank:

1 year ago
owentaylor888.307223 predicted that NCNA for 2022-08-08 is going

Rank:

2 years ago
JS predicted that NCNA for 2022-03-24 is going $0.91 (-11.55%)

2 years ago
novoma02 predicted that NCNA for 2022-03-24 is going

Rank:

2 years ago
JS predicted that NCNA for 2022-02-07 is going $3.12 (-4.29%)

2 years ago
nicoskammenos.299473 predicted that NCNA for 2022-02-07 is going

Rank:

2 years ago
JS predicted that NCNA for 2021-10-22 is going

2 years ago
JS predicted that NCNA for 2021-10-22 is going $2.56 (1.99%)

Click to get the best stock tips daily for free!

About NuCana plc

NuCana plc NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients with recurrent ovarian cancer; Phase Ib clinical trials for the treatment of patients with biliary trac... NCNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT